Neuland Laboratories Limited has informed the Exchange about General Updates
NEULANDLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Neuland Laboratories reported consolidated revenue from operations of Rs. 1,476.84 crore for FY25, down about 5.2% from Rs. 1,558.58 crore in FY24. Profit before exceptional items and tax fell sharply to Rs. 269.93 crore from Rs. 401.44 crore, a drop of nearly 33%, pointing to clear margin compression in the core API business. The company booked a one-time exceptional gain of Rs. 76.40 crore from transferring an investment property in Nanakramguda, Hyderabad through a perpetual lease, which lifted reported pre-tax profit to Rs. 346.33 crore and net profit to Rs. 260.11 crore (vs Rs. 300.08 crore). EPS stood at Rs. 202.74 vs Rs. 233.89. The Board recommended a final dividend of Rs. 12 per share (120%) and re-appointed Mr. Davuluri Saharsh Rao as Vice Chairman & Managing Director for five years. Statutory auditors MSKA & Associates issued an unmodified (clean) opinion on both standalone and consolidated results.
The sharp drop in core operating profit is a negative signal for shareholders, suggesting pricing pressure or cost headwinds in the API business, though it is partly cushioned by a one-off property gain. The 120% dividend is a positive return signal, but the underlying earnings weakness may weigh on the stock in the short term.